A gingivitis gum serum having a collagen building complex comprising between about 0.10 and 10.00 percent by weight of a stable Vitamin C derivative and between about 0.03 and 15.0 percent by weight of an amino acid complex primarily consisting of L-glycine, L-proline, L-lysine and mixtures thereof, a multi-mineral organo complex for healthy cell and tissue generation and an orally acceptable antimicrobial in a soft tissue delivery base for manual or vibratory application.

The present invention relates to methods and compositions for the delivery of cosmetics and medicants. In some embodiments, the invention relates to compositions comprising both hydrophobic and hydrophilic polymers. In preferred embodiments, the invention relates to the delivery of peptides, small molecules and other bioactive compounds using the compositions and methods disclosed herein.

The present invention relates to methods and compositions for the delivery of cosmetics and medicants. In some embodiments, the invention relates to compositions comprising both hydrophobic and hydrophilic polymers. In preferred embodiments, the invention relates to the delivery of peptides, small molecules and other bioactive compounds using the compositions and methods disclosed herein.

The present invention provides peptoid polymers and salts thereof that comprise hydrophobic and polar peptoid monomers and are capable of reducing or inhibiting the formation of ice crystals at sub 0° C. temperatures. Also provided are peptoid-peptide hybrids and salts thereof comprising the peptoid polymers provided herein. The peptoid polymers, peptoid-peptide hybrids, and salts thereof provided herein are useful for making cryoprotectant solutions. The peptoid polymers, peptoid-peptide hybrids, salts thereof, and cryoprotectant solutions provided herein are useful for making antifreeze solutions, frozen food products, and cosmetic care products. Also provided herein are methods for preserving a tissue, an organ, a cell, or a biological macromolecule using the compositions described herein.

The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.

The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.

The present invention relates to a consumer product comprising a plurality of microcapsules, to a method for obtaining a consumer product and to a use of a plurality of microcapsules in a such a consumer product.

The invention concerns a composition to be electrospun, which comprises a first compound to be electrospun and an electrospinning promoter, the function of which is to facilitate the electrospinning of the first compound, in particular to establish the electrospinning method in order to obtain regular fibers. A method to prepare the composition is also described, which provides a step of mixing a first compound to be electrospun with an electrospinning promoter.

The present invention relates to a solid phase cosmetic composition comprising a freeze-dried component of a composition comprising a functional component and a basic amino acid. A solid phase component according to the present invention has excellent re-dissolvability, and exhibits insignificant changes in the hardness and pH of the composition for dissolving the solid component even after re-dissolution, and thus a cosmetic having excellent stability can be provided.

The present invention relates to a solid phase cosmetic composition comprising a freeze-dried component of a composition comprising a functional component and a basic amino acid. A solid phase component according to the present invention has excellent re-dissolvability, and exhibits insignificant changes in the hardness and pH of the composition for dissolving the solid component even after re-dissolution, and thus a cosmetic having excellent stability can be provided.